---
id: aua-prostatitis-2024
title: "AUA 2024 Guideline: Diagnosis and Management of Prostatitis"
short_title: "AUA Prostatitis 2024"

organization: American Urological Association
collaborators: null
country: US
url: https://www.auanet.org/guidelines
doi: null
pmid: null
open_access: true

specialty: urology
guideline_type: clinical-practice
evidence_system: AUA
conditions:
  - prostatitis
  - chronic prostatitis
  - CPPS
  - acute bacterial prostatitis
tags:
  - antibiotics
  - alpha-blockers
  - pelvic pain
  - urinalysis
  - prostate massage

publication_date: 2024-04-01
previous_version_date: null
status: current
supersedes: null
superseded_by: null

pdf_path: null
has_pdf: false
last_reviewed: 2025-12-26
---

## Scope
2024 AUA guideline on the diagnosis and management of prostatitis syndromes.

## Key Recommendations

### Classification (NIH)
- **Category I**: Acute bacterial prostatitis.
- **Category II**: Chronic bacterial prostatitis.
- **Category III**: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) – IIIa inflammatory, IIIb non-inflammatory.
- **Category IV**: Asymptomatic inflammatory prostatitis.

### Acute Bacterial Prostatitis (Category I)
- **Presentation**: Fever, dysuria, perineal pain, acute urinary retention, tender prostate.
- **Evaluation**: Urinalysis, urine culture, avoid vigorous prostate massage.
- **Treatment**: Fluoroquinolones (ciprofloxacin, levofloxacin) or TMP-SMX x 2-4 weeks. Initial IV antibiotics if septic.

### Chronic Bacterial Prostatitis (Category II)
- Recurrent UTIs with same organism; quiescent periods between episodes.
- **Treatment**: Fluoroquinolone x 4-6 weeks preferred (penetrates prostatic tissue). Consider alpha-blocker for voiding symptoms.

### Chronic Prostatitis/CPPS (Category III)
- Most common and most challenging subtype.
- **Presentation**: Pelvic, perineal, or genital pain ≥3 months without proven infection.
- **Evaluation**: Rule out other causes; limited role for prostate massage/cultures.

#### Treatment (Multimodal Approach)
- **Alpha-Blockers (Tamsulosin, Alfuzosin)**: For obstructive voiding symptoms.
- **Antibiotics**: Trial of fluoroquinolone may be attempted initially, but benefit uncertain if no infection.
- **NSAIDs, Phytotherapy (Quercetin, Saw Palmetto)**: May provide symptomatic relief.
- **Pelvic Floor Physical Therapy**: Effective for myofascial pain and trigger points.
- **Neuromodulators (Amitriptyline, Gabapentin)**: For neuropathic pain component.
- **Psychotherapy, Stress Reduction**: Address psychosocial contributors.

### Category IV
- Incidental finding; typically no treatment required.
